Question 1

What specific benefits do you think solriamfetol might offer for my fatigue?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Solriamfetol for the Treatment of Multiple Sclerosis Fatigue clinical trial (NCT06170970). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Solriamfetol for the Treatment of Multiple Sclerosis Fatigue clinical trial (NCT06170970). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking solriamfetol?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Solriamfetol for the Treatment of Multiple Sclerosis Fatigue clinical trial (NCT06170970). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the participation schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Solriamfetol for the Treatment of Multiple Sclerosis Fatigue clinical trial (NCT06170970). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my fatigue be measured during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Solriamfetol for the Treatment of Multiple Sclerosis Fatigue clinical trial (NCT06170970). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Solriamfetol for the Treatment of Multiple Sclerosis Fatigue clinical trial (NCT06170970). Contact the study team or your healthcare provider for specific answers.

What this study is about